Healthcare Contract Development And Manufacturing Organization Market
Request Sample Report
Healthcare Contract Development And Manufacturing Organization Market Size and Growth
The Healthcare Contract Development and Manufacturing Organization (CDMO) market is experiencing robust growth, driven by increasing outsourcing in drug development and production. The market size is projected to reach approximately $150 billion by 2027, reflecting a compound annual growth rate of around 8%. Rising demand for specialized services further fuels market expansion. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Catalent
◍ Thermo Fisher Scientific
◍ Lonza
◍ Boehringer Ingelheim
◍ Fareva
◍ Recipharm
◍ Aenova
◍ AbbVie
◍ Baxter
◍ Nipro Corp
◍ Sopharma
◍ Famar
◍ Vetter
◍ Shandong Xinhua
◍ Piramal
◍ Mylan
◍ Dr. Reddy’s
◍ Zhejiang Hisun
The Healthcare Contract Development and Manufacturing Organization (CDMO) market is competitive, with key players like Catalent, Thermo Fisher Scientific, and Lonza offering comprehensive services. These companies facilitate drug development and production, enhancing efficiency. Notable sales figures include Catalent ($3.2 billion), Thermo Fisher ($40 billion), and Lonza ($5.5 billion), driving market growth.
Request Sample Report
Market Segmentation
By Application
Small Medium Enterprise
Large Enterprise
Request Sample Report
By Product
Contract Development
Contract Manufacturing
Market Growth
Request Sample Report
$ 266.68 Billion
